Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Return on Capital Employed (2022 - 2025)

Stoke Therapeutics has reported Return on Capital Employed over the past 4 years, most recently at 0.06% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.06% for Q4 2025, up 36.0% from a year ago — trailing twelve months through Dec 2025 was 0.06% (up 36.0% YoY), and the annual figure for FY2025 was 0.07%, up 41.0%.
  • Return on Capital Employed for Q4 2025 was 0.06% at Stoke Therapeutics, down from 0.08% in the prior quarter.
  • Over the last five years, Return on Capital Employed for STOK hit a ceiling of 0.13% in Q1 2025 and a floor of 0.65% in Q1 2024.
  • Median Return on Capital Employed over the past 4 years was 0.44% (2022), compared with a mean of 0.32%.
  • Biggest five-year swings in Return on Capital Employed: decreased -21bps in 2024 and later soared 78bps in 2025.
  • Stoke Therapeutics' Return on Capital Employed stood at 0.44% in 2022, then dropped by -27bps to 0.56% in 2023, then grew by 26bps to 0.42% in 2024, then surged by 85bps to 0.06% in 2025.
  • The last three reported values for Return on Capital Employed were 0.06% (Q4 2025), 0.08% (Q3 2025), and 0.11% (Q2 2025) per Business Quant data.